NDC 55390-370
Topotecan Hydrochloride
Topotecan Hydrochloride
Topotecan Hydrochloride is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Bedford Laboratories. The primary component is Topotecan Hydrochloride.
Product ID | 55390-370_654d0d44-73a6-baa4-78ec-8fa492237dab |
NDC | 55390-370 |
Product Type | Human Prescription Drug |
Proprietary Name | Topotecan Hydrochloride |
Generic Name | Topotecan Hydrochloride |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2011-04-18 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA201191 |
Labeler Name | Bedford Laboratories |
Substance Name | TOPOTECAN HYDROCHLORIDE |
Active Ingredient Strength | 4 mg/4mL |
Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |